Fredun Pharmaceuticals Ltd. (FREDUN) Share Price rises 10% today
- October 7, 2026
- Posted by: Kunal Singla
- Category: News
Fredun Pharmaceuticals Ltd. Share Price is in focus after rising 10% to Rs 1,548.90, lifting the company’s market capitalisation to Rs 2,334.52 Cr. The move took the stock above its previous close of Rs 1,408.10 and placed it at the day’s high as well, with trading spanning Rs 1,415.00 to Rs 1,548.90. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the Fredun Pharmaceuticals Ltd. Share Price move a data-led story rather than a news-led one, which is why the current valuation and healthcare peer context matter today. For readers tracking Fredun Pharmaceuticals Ltd. Share Price Today, the key question is whether the current fundamentals and sector benchmark still justify the market’s latest repricing. Univest data keeps the focus on what changed in price and how the company compares within Pharmaceuticals & Drugs.
Fredun Pharmaceuticals Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,548.9 |
| Previous Close | Rs 1,408.1 |
| Today's Move | Rs 140.8 (+10%) |
| Open | Rs 1,424.95 |
| High | Rs 1,548.9 |
| Low | Rs 1,415 |
| Market Capitalisation | Rs 2,334.52 crore |
| Market Cap Category | Small Cap |
Fredun Pharmaceuticals Ltd. (FREDUN) rose to Rs 1,548.9 from the previous close of Rs 1,408.1, a move of Rs 140.8 or 10%. The stock opened at Rs 1,424.95, reached a high of Rs 1,548.9, recorded a low of Rs 1,415.
Fredun Pharmaceuticals Ltd. Share Price Today shows a clean intraday rise of 10%, with the stock moving from Rs 1,408.10 to Rs 1,548.90 and touching the day’s high at the same level. The opening price was Rs 1,424.95, and the day’s low stood at Rs 1,415.00, which frames the move as a steady climb rather than a narrow last-minute change. Fredun Pharmaceuticals Ltd. Share Price has therefore added Rs 140.80 from the previous close while staying within a defined intraday range. The market capitalisation at Rs 2,334.52 Cr keeps Fredun Pharmaceuticals Ltd. Share Price in the listed healthcare universe with meaningful scale, even as the day’s move remains the main event. For investors following Fredun Pharmaceuticals Ltd. Share Price, the price action confirms a strong same-day share price gain, while the next layer of analysis sits in the company’s fundamentals.
Fredun Pharmaceuticals Ltd. (FREDUN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,334.52 crore |
| P/E Ratio | 54.89x |
| P/B Ratio | 7.89x |
| ROE | 16.09% |
| ROCE | 21.34% |
| EPS | Rs 25.65 |
| Book Value Per Share | Rs 178.46 |
| Dividend Yield | 0.02% |
Fredun Pharmaceuticals Ltd. (FREDUN) fundamental metrics show P/E 54.89x, P/B 7.89x, ROE 16.09%, ROCE 21.34%. These ratios show where the company stands today and are not a call to buy or sell.
Fredun Pharmaceuticals Ltd. has a market capitalisation of Rs 2,334.52 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 54.89x, P/B at 7.89x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.09% and ROCE of 21.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.65, book value per share of Rs 178.46, dividend yield of 0.02%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.15x, median ROE of 11.73%, median ROCE of 13.63%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 54.89x |
| Benchmark Median P/E | 32.15x |
| Benchmark Average P/E | 48.45x |
| Benchmark P/E Range | 3.58x to 695.67x |
| Company P/B Ratio | 7.89x |
| Benchmark Median P/B | 2.96x |
| Company ROE | 16.09% |
| Benchmark Median ROE | 11.73% |
| Company ROCE | 21.34% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 2,334.52 crore |
| Benchmark Median Market Cap | Rs 816.35 crore |
Fredun Pharmaceuticals Ltd. (FREDUN) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Fredun Pharmaceuticals Ltd. (FREDUN) has a P/E ratio of 54.89x, which is above the benchmark median of 32.15x, a difference of +70.73%. A P/E difference of this kind is a reference point rather than a recommendation.
Fredun Pharmaceuticals Ltd. (FREDUN) has a ROE of 16.09%, which is above the benchmark median of 11.73%, a difference of +37.17%. Fredun Pharmaceuticals Ltd. (FREDUN) has a ROCE of 21.34%, which is above the benchmark median of 13.63%, a difference of +56.57%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,27,561.49 | 35.73 | 5 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,44,572.22 | 86.63 | 14.35 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,80,870.62 | 83.33 | 20.25 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,13,565.81 | 25.64 | 4.29 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,07,769.94 | 32.19 | 3.09 | 11.83 | 16 |
Fredun Pharmaceuticals Ltd. (FREDUN) has a P/E ratio of 54.89x compared with the displayed peer median of 35.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.09% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.34% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Fredun Pharmaceuticals Ltd. (FREDUN) has a market capitalisation of Rs 2,334.52 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Fredun Pharmaceuticals Ltd.
- Fredun Pharmaceuticals Ltd. Share Price rose 10% to Rs 1,548.90, making the day’s move the main market event.
- The stock’s previous close was Rs 1,408.10, and the day’s high matched the latest traded price.
- Fredun Pharmaceuticals Ltd. Share Price carries a P/E of 54.89 and a P/B of 7.89, both above the same-industry median.
- ROE of 16.09% and ROCE of 21.34% give the Fredun Pharmaceuticals Ltd. Share Price move a stronger return backdrop than many peers.
- Market capitalisation of Rs 2,334.52 Cr keeps Fredun Pharmaceuticals Ltd. Share Price relevant within Healthcare and Pharmaceuticals & Drugs.
About Fredun Pharmaceuticals Ltd.
Fredun Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of a same-industry benchmark universe that includes established pharma names across formulations, specialty products and related pharmaceutical activity. For investors reading Fredun Pharmaceuticals Ltd. Share Price, the business context matters because price moves in healthcare are often assessed alongside earnings quality, return ratios and relative valuation.
Share Price reflects a listed pharmaceutical company with a defined earnings base, book value and return profile. EPS of 25.65 and book value of Rs 178.46 give the market a per-share earnings and accounting-value reference, while dividend yield of 0.02% indicates a very small payout metric in the current profile. Univest places Fredun Pharmaceuticals Ltd. Share Price in the wider pharmaceuticals context rather than as a standalone price-only move, which helps readers connect the business model with the day’s share price rise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Fredun Pharmaceuticals Ltd. Share Price today?
Ans. Fredun Pharmaceuticals Ltd. Share Price is Rs 1,548.90, according to latest Univest data. It is up 10% from the previous close of Rs 1,408.10 and currently sits at the day’s high.
Why is Fredun Pharmaceuticals Ltd. Share Price rising today?
Ans. The price move is confirmed in Univest data; a company-specific reason has not been established. Fredun Pharmaceuticals Ltd. Share Price is higher by Rs 140.80 today, with the move visible in the intraday range.
What is the market cap of Fredun Pharmaceuticals Ltd.?
Ans. Fredun Pharmaceuticals Ltd. has a market capitalisation of Rs 2,334.52 Cr. That places Fredun Pharmaceuticals Ltd. Share Price above the benchmark median market cap in the same-industry comparison universe.
How does Fredun Pharmaceuticals Ltd. Share Price compare on valuation?
Ans. Fredun Pharmaceuticals Ltd. Share Price has a P/E ratio of 54.89 and a P/B ratio of 7.89. Both are above the same-industry medians of 32.15 and 2.96, respectively, in the comparison set.
What do ROE and ROCE show for Fredun Pharmaceuticals Ltd.?
Ans. Fredun Pharmaceuticals Ltd. reports ROE of 16.09% and ROCE of 21.34%. Those figures place Fredun Pharmaceuticals Ltd. Share Price above the benchmark median and average in the same-industry universe.
What is the EPS and book value for Fredun Pharmaceuticals Ltd. Share Price?
Ans. Fredun Pharmaceuticals Ltd. has EPS of 25.65 and book value of Rs 178.46. EPS shows earnings per share, while book value reflects the accounting net worth behind each Fredun Pharmaceuticals Ltd. Share Price unit.
How does Fredun Pharmaceuticals Ltd. Share Price compare with peers?
Ans. Fredun Pharmaceuticals Ltd. Share Price trades at a higher P/E than Zydus Lifesciences Ltd., Cipla Ltd. and Sun Pharmaceutical Industries Ltd., but below Divi's Laboratories Ltd. and Torrent Pharmaceuticals Ltd. on valuation.
Is Fredun Pharmaceuticals Ltd. Share Price in the Healthcare sector?
Ans. Yes, Fredun Pharmaceuticals Ltd. Share Price belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector context is useful when comparing valuation, returns and market capitalisation across listed pharma companies.
Track Fredun Pharmaceuticals Ltd. Share Price on Univest
Use Fredun Pharmaceuticals Ltd. (FREDUN) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Fredun Pharmaceuticals Ltd. Share Price on Univest for the live price, the latest share price update, valuation ratios, 52-week levels and broader market insights. Univest also helps users compare Fredun Pharmaceuticals Ltd. Share Price with healthcare peers, review the market cap and follow the same company page as fresh information appears during the trading day.
